NeoTYPE® Head & Neck Tumor Profile
Also known as: Head & Neck Tumor Profile
Use
The NeoTYPE Head & Neck Tumor Profile provides comprehensive analysis of 34 biomarkers through a combination of next-generation sequencing (NGS), FISH, IHC, and other molecular methods. This test is designed to guide treatment decisions by offering insight into the genetic landscape of head and neck tumors. NGS includes 27 genes and two biomarkers, allowing detailed genetic profiling and identification of mutations and genomic alterations in tumors. The inclusion of multiple methodologies ensures a thorough evaluation, facilitating tailored treatment approaches based on the individual tumor profile.
Special Instructions
Not provided.
Limitations
The test may not detect all possible genetic mutations and may have limitations if the tumor sample is insufficient or degraded. Reflex testing is contingent on specific initial results and may delay final reporting. The interpretative accuracy of the analyses depends on sample quality, including fixation method and preservation. Extensive genetic rearrangements or rare mutations beyond the targeted regions may not be identified, and further genetic consultation may be necessary.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
14 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
Not provided
Container
Paraffin block preferred
Collection Instructions
Please use 10% buffered formalin fixative. Do not use zinc fixatives.
Storage Instructions
Use cold pack for transport, making sure cold pack is not in direct contact with specimen.